These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 193789)

  • 21. [Determination of the species specificity of interferons in the translation of the their mRNA from various cell cultures].
    Nosik DN; Novokhatskiĭ AS; Liakh LA; Khil'ko SN; Aspetov RD
    Antibiotiki; 1983 Jan; 28(1):27-31. PubMed ID: 6187280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of oxygen on the antiviral activity of human interferon in cell culture].
    Krivokhatskaia LD; Povolotskiĭ IaL; Spivak NIa
    Antibiotiki; 1980 Jun; 25(6):464-6. PubMed ID: 6156641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Rubin BY; Gupta SL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of exogenous interferon on virus-specific immune cytolysis].
    Ovsiannikova NV; Karmysheva VIa
    Vopr Virusol; 1980; (1):72-6. PubMed ID: 6158178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity in interferon-treated bovine tracheal organ cultures.
    Fulton RW; Root SK
    Infect Immun; 1978 Aug; 21(2):672-3. PubMed ID: 211089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
    Ito Y; Montagnier L
    Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro.
    Edelman R; Wheelock EF
    J Virol; 1967 Dec; 1(6):1139-49. PubMed ID: 4316248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycoplasma-associated induction of interferon in ovine leukocytes.
    Rinaldo CR; Overall JC; Cole BC; Glasgow LA
    Infect Immun; 1973 Nov; 8(5):796-803. PubMed ID: 4356073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A convenient and rapid cytopathic effect inhibition assay for interferon.
    Familletti PC; Rubinstein S; Pestka S
    Methods Enzymol; 1981; 78(Pt A):387-94. PubMed ID: 6173617
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon-mediated inhibition of virus penetration.
    Whitaker-Dowling PA; Wilcox DK; Widnell CC; Youngner JS
    Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1083-6. PubMed ID: 6189119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A micro assay for mouse and human interferon. II. Dose-response in different in cell-virus systems.
    Dahl H
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):359-64. PubMed ID: 4360138
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action.
    Jordan GW
    Virology; 1972 May; 48(2):425-32. PubMed ID: 4337029
    [No Abstract]   [Full Text] [Related]  

  • 33. [The interaction of interferon antibodies and leukocytes in experiments in vitro].
    Marchenko VI; Pokidysheva LN
    Vopr Virusol; 1971; 16(4):456-9. PubMed ID: 4332924
    [No Abstract]   [Full Text] [Related]  

  • 34. Purification of human fibroblast interferon prepared in the absence of serum.
    Knight E
    Methods Enzymol; 1981; 78(Pt A):417-21. PubMed ID: 6173623
    [No Abstract]   [Full Text] [Related]  

  • 35. Antagonism in action between mouse or human interferon and platelet growth factor.
    Inglot AD; Oleszak E; Kisielow B
    Arch Virol; 1980; 63(3-4):291-6. PubMed ID: 6243926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological properties of human leukocyte interferon components.
    Paucker K; Dalton BJ; Törmä ET; Ogburn CA
    J Gen Virol; 1977 May; 35(2):341-51. PubMed ID: 69014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons.
    Stewart II WE; De Somer P; Edy VG; Paucker K; Berg K; Ogburn CA
    J Gen Virol; 1975 Mar; 26(3):327-31. PubMed ID: 164521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference activity and sensitivity to interferon of original and "cold" strains of adenovirus types 1 and 2.
    Lysov VV; Aksenov OA; Rudenko VI; Moshkin SA; Yurlova TI; Smorodintsev AA; Selivanov AA
    Acta Virol; 1971 Sep; 15(5):387-92. PubMed ID: 4399137
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon production by mouse leukocytes in vitro and in vivo.
    GLASGOW LA; HABEL K
    J Exp Med; 1963 Jan; 117(1):149-60. PubMed ID: 13948365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.